Bettina Manduca

Bettina Manduca practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Bettina Manduca's NPI, 1538573779, was assigned on June 16, 2014. Bettina Manduca holds New York license 285737.

Bettina Manduca's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Bettina Manduca also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Bettina Manduca's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. The medical group on file is Mount Sinai Doctors Long Island. Dmand AI also links Bettina Manduca to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Bettina Manduca practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Bettina Manduca's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Bettina Manduca is licensed in New York.

CMS data shows 364 Medicare services from Bettina Manduca across 8 procedure codes in 2024, for 65 Medicare patients. Medicare paid $18,114 for them. Every service was in an office.

CMS counts 65 Medicare patients who saw Bettina Manduca in 2024. The largest group is 75 to 84, with 24 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 58% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Bettina Manduca's median patient age at 57, with 73% women.

In 2024, Bettina Manduca wrote 7,159 Medicare Part D claims for 512 patients. 83% of them were for generic drugs. CMS names the drug for 6,611 of them, across 97 drugs with 11 or more claims each, at $560,874 in total drug cost. In 2023, CMS named 6,144 claims across 90 drugs.

Bettina Manduca accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Bettina Manduca as offering telehealth.

CMS Open Payments shows 8 general payments to Bettina Manduca from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $241.